Bionano Q3 Revenue Up 12% to $8.3M; FY26 Guidance Reiterated at $31-33M
BNGO sits 21% above its 52-week low of $1.
Summary
Bionano reported Q3 2026 revenue of $8.3M (up 12%), a 48% gross margin and 12% lower operating expenses, and reiterated FY26 revenue guidance of $31-33M. With cash of $4.355M against a $6.45M quarterly net loss, financing needs stay front and center.
Key Events · Earnings and Guidance · BNGO
-
Q3 Revenue Grows 12% to $8.3M
Total revenue rose to $8.3M from $7.4M a year earlier, with consumables up 24% to $4.7M and 9,870 flowcells sold versus 8,390.
-
Margins Improve, Expenses Cut 12%
Gross margin was 48% versus 46%, and operating expenses fell 12% to $10.5M ($8.8M adjusted), narrowing the quarterly net loss to $6.45M from $8.50M.
-
Cash Thin Against Quarterly Burn
Cash and equivalents were $4.355M at September 30, 2026, versus a $6.45M net loss for the quarter; the going concern warning previously disclosed in the Q2 10-Q remains the key risk.
-
FY26 Guidance Reiterated at $31-33M
Nine-month revenue of $23.1M leaves roughly $8-10M needed in Q4 to land inside the reiterated $31-33M range.
Analysis · BNGO · Industrial Applications And Services
The top line is moving in the right direction: revenue grew 12%, consumables rose 24%, and flowcell placements climbed 18%, all signs that the OGM installed base is being used more intensively. Gross margin also improved to 48% while operating expenses fell 12%. The balance sheet, however, is the real story. Cash and equivalents stood at $4.355M at September 30 against a $6.45M quarterly net loss, so the company still needs to raise money to keep operating, and the going concern warning previously disclosed in the Q2 10-Q remains the central risk. Reiterating $31-33M FY26 guidance against $23.1M booked in the first nine months implies roughly $8-10M in Q4, meaning even the low end requires a modest sequential step-up.
How filings like this one have moved
In the 30 days to Nov 11, 2026, 36.6% of the 3434 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BNGO was trading at $1.21 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $17.2M. The 52-week trading range was $1.00 to $2.23. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.